Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Other Operating Expenses (2021 - 2025)

PAVmed has reported Other Operating Expenses over the past 5 years, most recently at $334000.0 for Q4 2025.

  • Quarterly results put Other Operating Expenses at $334000.0 for Q4 2025, up 64.53% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (down 91.03% YoY), and the annual figure for FY2025 was $1.1 million, down 93.33%.
  • Other Operating Expenses for Q4 2025 was $334000.0 at PAVmed, up from $256000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for PAVM hit a ceiling of $7.9 million in Q4 2022 and a floor of -$17.1 million in Q1 2022.
  • Median Other Operating Expenses over the past 5 years was $1.4 million (2021), compared with a mean of $1.0 million.
  • Biggest five-year swings in Other Operating Expenses: surged 542.7% in 2024 and later plummeted 95.66% in 2025.
  • PAVmed's Other Operating Expenses stood at $3.9 million in 2021, then surged by 101.92% to $7.9 million in 2022, then tumbled by 87.31% to $1.0 million in 2023, then tumbled by 79.7% to $203000.0 in 2024, then skyrocketed by 64.53% to $334000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $334000.0 (Q4 2025), $256000.0 (Q3 2025), and $261000.0 (Q2 2025) per Business Quant data.